American Assoc. for Cancer Research (AACR): Career Development Awards for Immuno-oncology Research

Emphasis for one of the grants should be placed on biological mechanisms underlying checkpoint inhibitor resistance and/or approaches to overcome this resistance. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to immuno-oncology. Funding: $170,000-$200,000 for 2 years.

http://www.aacr.org/Funding/Pages/Funding-Detail.aspx?ItemID=65#.WEeb17J97yN